MMSI
Merit Medical Systems, Inc. NASDAQ Listed May 14, 1990$62.32
After hrs
$61.27
+0.00%
Mkt Cap $3.7B
52w Low $59.74
6.4% of range
52w High $100.19
50d MA $69.32
200d MA $81.00
P/E (TTM)
28.6x
EV/EBITDA
17.1x
P/B
2.3x
Debt/Equity
0.6x
ROE
8.1%
P/FCF
24.2x
RSI (14)
—
ATR (14)
—
Beta
0.65
50d MA
$69.32
200d MA
$81.00
Avg Volume
732.8K
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
1600 West Merit Parkway · South Jordan, UT 84095 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.84 | 0.94 | +11.9% | 68.18 | -1.7% | -9.0% | -9.0% | -11.4% | -9.6% | -8.6% | — |
| Feb 24, 2026 | AMC | 0.96 | 1.04 | +8.3% | 82.43 | +1.6% | -3.9% | -5.3% | -6.4% | -7.2% | -9.2% | — |
| Oct 30, 2025 | AMC | 0.82 | 0.92 | +12.2% | 83.04 | +7.0% | +5.4% | +5.2% | +6.5% | +4.9% | +4.2% | — |
| Jul 30, 2025 | AMC | 0.86 | 1.01 | +17.4% | 82.96 | +2.2% | +2.3% | +2.2% | +2.9% | +1.8% | +0.7% | — |
| Apr 24, 2025 | AMC | 0.75 | 0.86 | +14.8% | 94.67 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% | — |
| Feb 25, 2025 | AMC | 0.82 | 0.93 | +13.4% | 102.03 | -3.4% | -1.5% | -3.5% | +0.0% | +1.0% | -0.1% | — |
| Oct 30, 2024 | AMC | 0.80 | 0.86 | +7.5% | 94.90 | +1.2% | +4.0% | +4.1% | +4.4% | +4.1% | +8.0% | — |
| Aug 1, 2024 | AMC | 0.88 | 0.92 | +4.5% | 84.12 | +3.5% | +5.5% | +3.9% | +6.5% | +5.4% | +8.0% | — |
| Apr 30, 2024 | AMC | 0.71 | 0.77 | +8.5% | 74.10 | +0.8% | +3.4% | +3.9% | +6.6% | +7.3% | +8.6% | — |
| Feb 28, 2024 | AMC | 0.77 | 0.81 | +5.2% | 80.13 | +1.3% | -4.9% | -4.8% | -4.5% | -6.3% | -6.6% | — |
| Oct 26, 2023 | AMC | 0.65 | 0.75 | +15.4% | 63.49 | +5.5% | +8.7% | +4.7% | +8.3% | +11.9% | +11.2% | — |
| Jul 25, 2023 | AMC | 0.75 | 0.81 | +8.0% | 81.53 | -4.3% | -11.1% | -11.2% | -9.8% | -8.4% | -9.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Needham | Maintains | Buy → Buy | — | $68.18 | $67.00 | -1.7% | -9.0% | -9.0% | -11.4% | -9.6% | -8.6% |
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $68.18 | $67.00 | -1.7% | -9.0% | -9.0% | -11.4% | -9.6% | -8.6% |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $68.18 | $67.00 | -1.7% | -9.0% | -9.0% | -11.4% | -9.6% | -8.6% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $68.18 | $67.00 | -1.7% | -9.0% | -9.0% | -11.4% | -9.6% | -8.6% |
| Apr 20 | Barrington Research | Maintains | Outperform → Outperform | — | $70.93 | $70.56 | -0.5% | -1.6% | -4.3% | -1.7% | -3.3% | -3.3% |
| Apr 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.10 | $70.83 | +1.0% | +1.2% | -0.4% | -3.2% | -0.5% | -2.1% |
| Apr 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $67.81 | $67.36 | -0.7% | -0.6% | +2.1% | +1.2% | +0.7% | +4.1% |
| Apr 1 | Needham | Maintains | Buy → Buy | — | $68.93 | $69.45 | +0.8% | -1.0% | -1.8% | -1.6% | -2.2% | +0.4% |
| Feb 26 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $79.23 | $78.28 | -1.2% | -1.5% | -2.6% | -3.4% | -5.5% | -6.4% |
| Feb 25 | Barrington Research | Maintains | Outperform → Outperform | — | $82.43 | $83.76 | +1.6% | -3.9% | -5.3% | -6.4% | -7.2% | -9.2% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $82.43 | $83.76 | +1.6% | -3.9% | -5.3% | -6.4% | -7.2% | -9.2% |
| Feb 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $81.59 | $81.09 | -0.6% | +1.7% | +0.3% | +0.8% | +0.0% | +1.0% |
| Jan 9 | Needham | Maintains | Buy → Buy | — | $93.18 | $91.61 | -1.7% | -7.3% | -10.7% | -13.0% | -12.3% | -13.8% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $86.85 | $86.85 | +0.0% | +0.4% | +0.7% | +1.0% | +1.2% | +0.9% |
| Nov 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $87.40 | $80.03 | -8.4% | -2.6% | -1.8% | -3.7% | -4.2% | -2.9% |
| Nov 14 | Barrington Research | Maintains | Outperform → Outperform | — | $87.40 | $80.03 | -8.4% | -2.6% | -1.8% | -3.7% | -4.2% | -2.9% |
| Nov 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.40 | $80.03 | -8.4% | -2.6% | -1.8% | -3.7% | -4.2% | -2.9% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $83.04 | $88.86 | +7.0% | +5.4% | +5.2% | +6.5% | +4.9% | +4.2% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $83.04 | $88.86 | +7.0% | +5.4% | +5.2% | +6.5% | +4.9% | +4.2% |
| Oct 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $83.04 | $88.86 | +7.0% | +5.4% | +5.2% | +6.5% | +4.9% | +4.2% |
| Oct 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $80.47 | $81.62 | +1.4% | +0.4% | +1.7% | +3.4% | +4.6% | +5.0% |
| Oct 7 | Barrington Research | Maintains | Outperform → Outperform | — | $83.31 | $83.93 | +0.7% | -0.7% | +0.5% | -1.0% | -5.2% | -4.7% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $83.59 | $83.54 | -0.1% | +0.2% | -0.6% | -4.2% | -4.1% | -3.3% |
| Jul 31 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.96 | $84.75 | +2.2% | +2.3% | +2.2% | +2.9% | +1.8% | +0.7% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $82.96 | $84.75 | +2.2% | +2.3% | +2.2% | +2.9% | +1.8% | +0.7% |
| Jul 31 | Barrington Research | Maintains | Outperform → Outperform | — | $82.96 | $84.75 | +2.2% | +2.3% | +2.2% | +2.9% | +1.8% | +0.7% |
| Jul 31 | Raymond James | Maintains | Outperform → Outperform | — | $82.96 | $84.75 | +2.2% | +2.3% | +2.2% | +2.9% | +1.8% | +0.7% |
| Jul 18 | Needham | Maintains | Buy → Buy | — | $84.54 | $85.32 | +0.9% | -1.8% | -0.7% | -0.1% | +0.6% | -0.4% |
| Jul 8 | Needham | Maintains | Buy → Buy | — | $91.12 | $93.75 | +2.9% | +4.6% | +5.4% | +4.4% | +2.6% | +2.6% |
| May 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $95.11 | $93.86 | -1.3% | +0.3% | +1.5% | -0.7% | -0.3% | -0.1% |
| May 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $98.81 | $98.07 | -0.7% | -2.3% | -3.7% | -3.5% | -2.3% | -4.4% |
| May 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $98.81 | $98.07 | -0.7% | -2.3% | -3.7% | -3.5% | -2.3% | -4.4% |
| May 20 | Needham | Maintains | Buy → Buy | — | $98.10 | $98.30 | +0.2% | +0.7% | -1.6% | -3.0% | -2.8% | -1.6% |
| May 15 | Needham | Maintains | Buy → Buy | — | $97.01 | $96.76 | -0.3% | +0.6% | +1.9% | +1.1% | +1.9% | -0.5% |
| Apr 25 | Baird | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Needham | Maintains | Buy → Buy | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Barrington Research | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Raymond James | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.8% | +0.1% | -0.2% | -1.6% |
| Apr 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $91.45 | $92.24 | +0.9% | +2.5% | +3.5% | +3.5% | +4.4% | +3.6% |
| Apr 11 | Barrington Research | Maintains | Outperform → Outperform | — | $91.54 | $90.95 | -0.6% | +0.5% | +1.9% | +0.5% | -1.1% | -0.7% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $88.48 | $87.47 | -1.1% | +8.3% | +3.5% | +4.0% | +5.4% | +3.9% |
| Feb 26 | Barrington Research | Maintains | Outperform → Outperform | — | $102.03 | $98.53 | -3.4% | -1.5% | -3.5% | +0.0% | +1.0% | -0.1% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $102.03 | $98.53 | -3.4% | -1.5% | -3.5% | +0.0% | +1.0% | -0.1% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $102.03 | $98.53 | -3.4% | -1.5% | -3.5% | +0.0% | +1.0% | -0.1% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $102.03 | $98.53 | -3.4% | -1.5% | -3.5% | +0.0% | +1.0% | -0.1% |
| Jan 29 | Needham | Maintains | Buy → Buy | — | $109.03 | $110.07 | +1.0% | -0.5% | +1.2% | -0.1% | -1.6% | -0.9% |
| Jan 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $109.03 | $110.07 | +1.0% | -0.5% | +1.2% | -0.1% | -1.6% | -0.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Aronson Martha Goldberg | President and CEO | Buy | 2,000 | $60.44 | $121K | 49,792 | -1.70% | — |
| May 6, 2026 | Parra Raul Jr. | CFO AND TREASURER | Buy | 1,500 | $61.01 | $92K | 58,843 | -1.70% | — |
| May 5, 2026 | Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | Buy | 2,250 | $60.65 | $136K | 2,265 | -1.70% | — |
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Merit Medical disclosed additional revenue breakdown details but signaled it won't repeat this transparency going forward, likely disappointing investors seeking ongoing visibility into product-line performance.
Apr 13
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Merit Medical disclosed forward-looking statements with risk warnings, suggesting upcoming material announcements that may significantly impact stock performance, warranting careful monitoring for competitive, regulatory, or operational developments.
Apr 1
8-K · 7.01
! Medium
Merit Medical Systems Inc -- 8-K 7.01: Regulation FD Disclosure
Merit Medical Systems will host a February 24, 2026 earnings call to discuss Q4 2025 and full-year 2025 results, with live webcast access available.
Feb 24
8-K · 5.02
!!! Very High
Baxter International Inc. -- 8-K 5.02: Executive Change
Baxter International appointed Michael R. McDonnell as Executive Vice President effective February 13, 2026, signaling internal leadership development and potential changes to executive responsibilities.
Feb 12
Data updated apr 26, 2026 12:43pm
· Source: massive.com